APA

Hurley P. J., Marchionni L., Simons B. W., Ross A. E., Peskoe S. B., Miller R. M., Erho N., Vergara I. A., Ghadessi M., Huang Z., Gurel B., Park B. H., Davicioni E., Jenkins R. B., Platz E. A., Berman D. M. & Schaeffer E. M. (20121210). Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Hurley Paula J, Marchionni Luigi, Simons Brian W, Ross Ashley E, Peskoe Sarah B, Miller Rebecca M, Erho Nicholas, Vergara Ismael A, Ghadessi Mercedeh, Huang Zhenhua, Gurel Bora, Park Ben Ho, Davicioni Elai, Jenkins Robert B, Platz Elizabeth A, Berman David M and Schaeffer Edward M. 20121210. Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Hurley P. J., Marchionni L., Simons B. W., Ross A. E., Peskoe S. B., Miller R. M., Erho N., Vergara I. A., Ghadessi M., Huang Z., Gurel B., Park B. H., Davicioni E., Jenkins R. B., Platz E. A., Berman D. M. and Schaeffer E. M. (20121210). Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Hurley Paula J, Marchionni Luigi, Simons Brian W, Ross Ashley E, Peskoe Sarah B, Miller Rebecca M, Erho Nicholas, Vergara Ismael A, Ghadessi Mercedeh, Huang Zhenhua, Gurel Bora, Park Ben Ho, Davicioni Elai, Jenkins Robert B, Platz Elizabeth A, Berman David M and Schaeffer Edward M. Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. : Proceedings of the National Academy of Sciences of the United States of America. 20121210.